北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学临床肿瘤学院  > 期刊论文
学科主题: 临床医学
题名:
Efficacy and safety of every-2-weeks cetuximab combined with FOLFOX or FOLFIRI as first-line therapy in patients with KRAS wild-type metastatic colorectal cancer (mCRC): An Asia-Pacific nonrandomized phase II study (APEC).
作者: Cheng, Ann-Lii; Cornelio, Gerardo H.; Shen, Lin; Price, Timothy Jay; Yang, Tsai-Shen; Chung, Ik-Joo; Dai, Guanghai; Lin, Jen-Kou; Sharma, Atul; Yeh, Kun-Huei; Ma, Brigette; Zaatar, Adel; Guan, Zhongzhen; Masood, Nehal; Srimuninnimit, Vichien; Yau, Thomas Cheung; Sarholz, Barbara; Lim, Robert S. C.
刊名: JOURNAL OF CLINICAL ONCOLOGY
发表日期: 2013-05-20
卷: suppl.S, 期:15
收录类别: SCI ; ISTP
文章类型: Meeting Abstract
WOS标题词: Science & Technology
类目[WOS]: Oncology
研究领域[WOS]: Oncology
语种: 英语
WOS记录号: WOS:000335419603483
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/56699
Appears in Collections:北京大学临床肿瘤学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Natl Taiwan Univ Hosp, Taipei, Taiwan
2.San Juan De Dios Hosp, Pasay City, Philippines
3.Peking Univ, Canc Hosp, Minist Educ, Dept Gastrointestinal Oncol,Key Lab Carcinogenesi, Beijing 100871, Peoples R China
4.Queen Elizabeth Hosp, Adelaide, SA, Australia
5.Chang Gung Mem Hosp, Taoyuan, Taiwan
6.Chonnam Natl Univ, Hawsun Hosp, Hwasuneup, South Korea
7.Peoples Liberat Army, Gen Hosp, Beijing, Peoples R China
8.Taipei Vet Gen Hosp, Taipei, Taiwan
9.All India Inst Med Sci, New Delhi, India
10.Chinese Univ Hong Kong, Prince Wales Hosp, Sha Tin, Hong Kong, Peoples R China
11.Mt Miriam Canc Hosp, George Town, Malaysia
12.Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
13.Aga Khan Univ & Hosp, Karachi, Pakistan
14.Siriraj Hosp, Bangkok, Thailand
15.Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China
16.Merck KGaA, Darmstadt, Germany
17.Natl Univ Hlth Syst, Singapore, Singapore

Recommended Citation:
Cheng, Ann-Lii,Cornelio, Gerardo H.,Shen, Lin,et al. Efficacy and safety of every-2-weeks cetuximab combined with FOLFOX or FOLFIRI as first-line therapy in patients with KRAS wild-type metastatic colorectal cancer (mCRC): An Asia-Pacific nonrandomized phase II study (APEC).[J]. JOURNAL OF CLINICAL ONCOLOGY,2013,suppl.S(15).
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Cheng, Ann-Lii]'s Articles
[Cornelio, Gerardo H.]'s Articles
[Shen, Lin]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Cheng, Ann-Lii]‘s Articles
[Cornelio, Gerardo H.]‘s Articles
[Shen, Lin]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace